Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 9:30 AM UTC
| NCT Number | NCT05776524 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer |
| Phase | PHASE2 |
| Target Enrollment | 46 participants |
| Active Locations | 1 sites in the US |
| Sponsor | THERABIONIC INC. |
| Last Updated on CT.gov | March 25, 2025 (Mar 25, 2025) |
As of July 19, 2026: Clinical trial NCT05776524 is currently recruiting participants. This phase2 study for pancreatic cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by THERABIONIC INC.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05776524 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05776524 was last updated Mar 25, 2025 (March 25, 2025). HelloStudys verifies this status automatically.